These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 2830146
1. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts. Robberecht P, Waelbroeck M, De Neef P, Tastenoy M, Gourlet P, Cogniaux J, Christophe J. FEBS Lett; 1988 Feb 15; 228(2):351-5. PubMed ID: 2830146 [Abstract] [Full Text] [Related]
2. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes. Robberecht P, De Neef P, Gourlet P, Cauvin A, Coy DH, Christophe J. Regul Pept; 1989 Feb 15; 26(2):117-26. PubMed ID: 2552509 [Abstract] [Full Text] [Related]
3. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3. Abello J, Damien C, De Neef P, Tastenoy M, Hooghe R, Robberecht P, Christophe J. Eur J Biochem; 1989 Aug 01; 183(2):263-7. PubMed ID: 2547606 [Abstract] [Full Text] [Related]
4. VIP receptors in human SUP-T1 lymphoblasts. Christophe J, Cauvin A, Vervisch E, Buscail L, Damien C, Abello J, Gourlet P, Robberecht P. Digestion; 1990 Aug 01; 46 Suppl 2():148-55. PubMed ID: 1979777 [Abstract] [Full Text] [Related]
5. Secretin receptors in human pancreatic membranes. Robberecht P, De Neef P, Waelbroeck M, Camus JC, Scemama JL, Fourmy D, Pradayrol L, Vaysse N, Christophe J. Pancreas; 1988 Aug 01; 3(5):529-35. PubMed ID: 3186683 [Abstract] [Full Text] [Related]
6. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes. Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers A, Vandermeers-Piret MC, Robberecht P, Christophe J. Biochim Biophys Acta; 1991 Jul 22; 1066(2):245-51. PubMed ID: 1649637 [Abstract] [Full Text] [Related]
7. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini. Zhou ZC, Gardner JD, Jensen RT. Am J Physiol; 1989 Feb 22; 256(2 Pt 1):G283-90. PubMed ID: 2465694 [Abstract] [Full Text] [Related]
8. Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes. Robberecht P, Waelbroeck M, de Neef P, Camus JC, Vandermeers A, Vandermeers-Piret MC, Christophe J. FEBS Lett; 1984 Jun 25; 172(1):55-8. PubMed ID: 6329822 [Abstract] [Full Text] [Related]
9. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Le Meuth V, Farjaudon N, Bawab W, Chastre E, Rosselin G, Guilloteau P, Gespach C. Am J Physiol; 1991 Feb 25; 260(2 Pt 1):G265-74. PubMed ID: 1847591 [Abstract] [Full Text] [Related]
10. Pharmacological characterization of VIP receptors in human lung membranes. Robberecht P, Waelbroeck M, de Neef P, Camus JC, Coy DH, Christophe J. Peptides; 1988 Feb 25; 9(2):339-45. PubMed ID: 2836826 [Abstract] [Full Text] [Related]
11. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes. Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J. Eur J Biochem; 1987 Jun 01; 165(2):243-9. PubMed ID: 3036504 [Abstract] [Full Text] [Related]
12. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides. Bajo AM, Guijarro LG, Juarranz MG, Valenzuela P, Martinez P, Prieto JC. Biosci Rep; 1993 Apr 01; 13(2):69-77. PubMed ID: 8397008 [Abstract] [Full Text] [Related]
13. Recovery of VIP/helodermin- and prostaglandin E1-stimulated adenylate cyclase activities in desensitized SUP-T1 human lymphoblasts. Robberecht P, De Neef P, Abello J, Damien C, Coussaert E, Christophe J. Peptides; 1989 Apr 01; 10(5):1027-31. PubMed ID: 2558361 [Abstract] [Full Text] [Related]
14. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors. Gourlet P, Vandermeers A, Van Rampelbergh J, De Neef P, Cnudde J, Waelbroeck M, Robberecht P. Ann N Y Acad Sci; 1998 Dec 11; 865():247-52. PubMed ID: 9928018 [Abstract] [Full Text] [Related]
15. VIP and related peptides induce rapid homologous desensitization in the human lymphoma SUP T1 cell line. Robberecht P, De Neef P, Waelbroeck M, Tastenoy M, Christophe J. Peptides; 1989 Dec 11; 10(2):441-6. PubMed ID: 2474155 [Abstract] [Full Text] [Related]
16. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes. Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J. Eur J Biochem; 1986 Aug 15; 159(1):45-9. PubMed ID: 3017717 [Abstract] [Full Text] [Related]
17. Homologous and heterologous regulation of the helodermin/vasoactive-intestinal-peptide response in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3. Abello J, Damien C, Robberecht P, Hooghe R, Vandermeers A, Vandermeers-Piret MC, Christophe J. Eur J Biochem; 1989 Aug 01; 183(2):269-74. PubMed ID: 2547607 [Abstract] [Full Text] [Related]
18. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C, Bawab W, de Cremoux P, Calvo F. Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044 [Abstract] [Full Text] [Related]